 Bausch Lomb Corp.s stock BLCO, 5.39 debuted Friday with a slight gain, which helped justify the disappointing pricing overnight of the lenses and medical devices makers initial public offering. The company said late Thursday that its IPO priced at 18 a share, which was well below the expected range of between 21 and 24, as the company raised 630 million. 